Rock Springs Capital Management LP Q2 2019 Filing
Filed August 14, 2019
Portfolio Value
$2.8T
Holdings
135
Report Date
Q2 2019
Filing Type
13F-HR
All Holdings (135 positions)
| Stock | Value |
|---|---|
RYTMRHYTHM PHARMACEUTICALS INC | $5.2M |
NGMUSDNGM BIOPHARMACEUTICALS INC | $5.1M |
MGNXMACROGENICS INC | $5.1M |
—GAMIDA CELL LTD | $5.1M |
—MEDICINES CO | $5.0M |
—MOMENTA PHARMACEUTICALS INC | $5.0M |
—CHIASMA INC | $4.9M |
—ALDER BIOPHARMACEUTICALS INC | $4.7M |
ACRSACLARIS THERAPEUTICS INC | $4.4M |
AKROAKERO THERAPEUTICS INC | $4.3M |
CGENCOMPUGEN LTD | $4.2M |
—RESTORBIO INC | $4.1M |
—MYOVANT SCIENCES LTD | $4.1M |
ICPTUSDINTERCEPT PHARMACEUTICALS IN | $4.0M |
—LA JOLLA PHARMACEUTICAL CO | $3.9M |
—NABRIVA THERAPEUTICS PLC | $3.9M |
CLVSEURCLOVIS ONCOLOGY INC | $3.8M |
—MEDICINES CO | $3.6M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $3.5M |
ARVNARVINAS INC | $3.3M |
—FIVE PRIME THERAPEUTICS INC | $3.2M |
DVAXDYNAVAX TECHNOLOGIES CORP | $2.6M |
—CORREVIO PHARMA CORP | $2.6M |
—PARATEK PHARMACEUTICALS INC | $1.8M |
CRVSCORVUS PHARMACEUTICALS INC | $1.5M |
—RADIUS HEALTH INC | $1.4M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.3M |
—THERAVANCE BIOPHARMA INC | $1.3M |
KLDOKALEIDO BIOSCIENCES INC | $1.2M |
—PACIRA BIOSCIENCES | $1.0M |
NVV1NOVAVAX INC | $952K |
—DERMIRA INC | $865K |
CVETUSDCOVETRUS INC | $788K |
HRTXHERON THERAPEUTICS INC | $558K |
—PROTEOSTASIS THERAPEUTICS IN | $390K |
PreviousPage 2 of 2